Sign In
Buy BLFS
$27.25
-0.240 (-0.87%)
At Close: Jun 03, 2026
BioLife Solutions evo® Cold Chain Management Platform Now Supporting Over 100 Early Stage Cell & Gene Therapy Clinical Trials
12:00pm, Wednesday, 15'th Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today provided a
Week 29 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
11:58pm, Sunday, 12'th Jul 2020
Two new sample MDA Breakout Stocks for Week 29 with better than 10% short-term upside potential and now up an average 152.47% YTD.
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
04:45pm, Tuesday, 07'th Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Moving Average Crossover Alert: BioLife Solutions
01:08pm, Monday, 06'th Jul 2020
BioLife Solutions, Inc. (BLFS) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
BioLife (BLFS) Catches Eye: Stock Jumps 12.1%
10:57am, Monday, 06'th Jul 2020
BioLife (BLFS) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Tiziana Life Sciences (TLSA –
Here's Why BioLife Solutions Jumped Higher Today
06:48pm, Thursday, 02'nd Jul 2020
It doesn't look like the COVID-19 pandemic had much effect on sales of the company's bioproduction products for cell and gene therapies.
BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock
11:40am, Thursday, 02'nd Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 1)
AbbVie Inc (NYSE: ABBV)
ADC...
BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020
08:02pm, Wednesday, 01'st Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
BioLife Solutions Announces Proposed Public Offering of Common Stock
08:01pm, Wednesday, 01'st Jul 2020
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced
Edited Transcript of BLFS.OQ earnings conference call or presentation 14-May-20 8:30pm GMT
04:16pm, Friday, 26'th Jun 2020
Q1 2020 Biolife Solutions Inc Earnings Call
Is BioLife Solutions, Inc. (BLFS) A Good Stock To Buy?
03:45pm, Friday, 26'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filing
BioLife Solutions Inc (NASDAQ:BLFS) Position Lifted by Wellington Management Group LLP
06:59am, Friday, 26'th Jun 2020
Wellington Management Group LLP grew its position in shares of BioLife Solutions Inc (NASDAQ:BLFS) by 82.8% during the first quarter, according to the company in its most recent 13F filing with the Se
